Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Frontiers in Oncology
|
April 26, 2019
Detection of <i>ERBB2</i> (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort
Jeeyun Lee, Aleksandra Franovic, Yukimasa Shiotsu, et al.
Nature
|
June 9, 2012
An oxygen-regulated switch in the protein synthesis machinery
James Uniacke, Chet E Holterman, Gabriel Lachance, et al.
The Journal of Biological Chemistry
|
August 29, 2003
Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells
Lakshman Gunaratnam, Melissa Morley, Aleksandra Franovic, et al.
Nature Communications
|
September 4, 2015
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
Sunil J Advani, Maria Fernanda Camargo, Laetitia Seguin, et al.
Nature Medicine
|
November 15, 2011
A MEK-independent role for CRAF in mitosis and tumor progression
Ainhoa Mielgo, Laetitia Seguin, Miller Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2024
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
Eranga R Balasooriya, Qibiao Wu, Haley Ellis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations
Gang G Li, Romel Somwar, James Joseph, et al.
Nature Communications
|
November 26, 2016
MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
RaeAnna Wilson, Cristina Espinosa-Diez, Nathan Kanner, et al.
Journal of Medicinal Chemistry
|
January 24, 2024
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
John S Tyhonas, Lee D Arnold, Jason M Cox, et al.
Nature Cell Biology
|
April 22, 2014
An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition
Laetitia Seguin, Shumei Kato, Aleksandra Franovic, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Frontiers in Oncology
|
April 26, 2019
Detection of <i>ERBB2</i> (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort
Jeeyun Lee, Aleksandra Franovic, Yukimasa Shiotsu, et al.
Nature
|
June 9, 2012
An oxygen-regulated switch in the protein synthesis machinery
James Uniacke, Chet E Holterman, Gabriel Lachance, et al.
The Journal of Biological Chemistry
|
August 29, 2003
Hypoxia inducible factor activates the transforming growth factor-alpha/epidermal growth factor receptor growth stimulatory pathway in VHL(-/-) renal cell carcinoma cells
Lakshman Gunaratnam, Melissa Morley, Aleksandra Franovic, et al.
Nature Communications
|
September 4, 2015
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2
Sunil J Advani, Maria Fernanda Camargo, Laetitia Seguin, et al.
Nature Medicine
|
November 15, 2011
A MEK-independent role for CRAF in mitosis and tumor progression
Ainhoa Mielgo, Laetitia Seguin, Miller Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 4, 2024
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
Eranga R Balasooriya, Qibiao Wu, Haley Ellis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 25, 2016
Antitumor Activity of RXDX-105 in Multiple Cancer Types with <i>RET</i> Rearrangements or Mutations
Gang G Li, Romel Somwar, James Joseph, et al.
Nature Communications
|
November 26, 2016
MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
RaeAnna Wilson, Cristina Espinosa-Diez, Nathan Kanner, et al.
Journal of Medicinal Chemistry
|
January 24, 2024
Discovery of KIN-3248, An Irreversible, Next Generation FGFR Inhibitor for the Treatment of Advanced Tumors Harboring FGFR2 and/or FGFR3 Gene Alterations
John S Tyhonas, Lee D Arnold, Jason M Cox, et al.
Nature Cell Biology
|
April 22, 2014
An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition
Laetitia Seguin, Shumei Kato, Aleksandra Franovic, et al.
Page
of 3